Get the Stockscreener App
75.23
0.15%
-0.11
After Hours:
75.23
Hologic Inc stock is traded at $75.23, with a volume of 1.66M.
It is down -0.15% in the last 24 hours and up +0.05% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$75.34
Open:
$75.37
24h Volume:
1.66M
Relative Volume:
0.64
Market Cap:
$16.79B
Revenue:
$4.04B
Net Income/Loss:
$557.10M
P/E Ratio:
31.21
EPS:
2.4102
Net Cash Flow:
$916.70M
1W Performance:
+0.12%
1M Performance:
+0.05%
6M Performance:
+12.91%
1Y Performance:
+16.89%
1-Day Range:
$75.21
$75.40
1-Week Range:
$75.12
$75.48
52-Week Range:
$51.90
$75.48
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.23 | 16.82B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
506.88 | 179.76B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
176.66 | 51.48B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
86.72 | 42.38B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
48.89 | 39.09B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
257.06 | 36.79B | 5.40B | 1.49B | 1.78B | 10.12 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Downgrade | Argus | Buy → Hold |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-21-25 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-18-25 | Upgrade | Argus | Hold → Buy |
| Aug-06-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-27-25 | Reiterated | Needham | Hold |
| Mar-03-25 | Downgrade | Argus | Buy → Hold |
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Dow Update: How is Hologic Inc managing supply chain issues2025 Historical Comparison & Risk Managed Investment Entry Signals - baoquankhu1.vn
Hologic, Inc. Experiences Revision in Stock Evaluation Amidst Market Dynamics - Markets Mojo
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? - Yahoo Finance
Performance Recap: Is Hologic Inc stock a buy or sellJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Is Hologic Inc. stock resilient to inflationJuly 2025 Outlook & Risk Controlled Stock Pick Alerts - mfd.ru
Breast imaging Market 20262035 Top Key PlayersTop Key Players: - openPR.com
Biopsy Devices Market Set for Rapid Growth Amid Rising Cancer - openPR.com
(HOLX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Hologic stock hits 52-week high at 75.37 USD By Investing.com - Investing.com Nigeria
What risks investors should watch in Hologic Inc. stockMarket Trend Report & Technical Pattern Based Signals - mfd.ru
Hologic stock hits 52-week high at 75.37 USD - Investing.com
Hologic’s VP of marketing on the company’s WNBA foray - Medical Marketing and Media
Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally - GlobeNewswire Inc.
Readystate Asset Management LP Buys New Stake in Hologic, Inc. $HOLX - Defense World
Europe Diagnostic Imaging Market is expected to reach US$ 12.32 - openPR.com
T. Rowe Price discloses 2.7% Hologic (HOLX) stake in Schedule 13G/A - Stock Titan
European Commission OKs Blackstone, TPG's Purchase of Hologic - marketscreener.com
Molecular Diagnostics Market is expected to reach US$ 37.19 - openPR.com
How to Play Hologic Stock Post Q1 Earnings and Progress on Buyout? - The Globe and Mail
Hologic, Inc. (HOLX) Stock Report: Unpacking The 2.08% Upside Potential For Investors - DirectorsTalk Interviews
Is Wall Street bullish or bearish on Hologic stock? - MSN
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio - Quantisnow
Market Catalysts: Can Hologic Inc be the next market leaderGap Down & Short-Term Trading Alerts - baoquankhu1.vn
ING Groep NV Takes $1.94 Million Position in Hologic, Inc. $HOLX - MarketBeat
Can Hologic Inc. scale operations efficientlyTrade Entry Summary & Daily Profit Maximizing Trade Tips - mfd.ru
Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now? - Yahoo Finance
Hologic, Inc. $HOLX Shares Sold by Wealthfront Advisers LLC - MarketBeat
Illinois Municipal Retirement Fund Purchases 29,143 Shares of Hologic, Inc. $HOLX - MarketBeat
How The Narrative Surrounding Hologic (HOLX) Has Shifted With The US$79 All Cash Buyout - Yahoo Finance
Hologic, Inc. $HOLX is Sound Shore Management Inc CT's 9th Largest Position - MarketBeat
What are analysts’ price targets for Hologic Inc.Watch List & Weekly Breakout Watchlists - mfd.ru
Hologic, Inc. $HOLX Shares Sold by Allianz Asset Management GmbH - MarketBeat
China regulator approves Blackstone, TPG acquisition of medtech firm Hologic - Reuters
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Is Wall Street Bullish or Bearish on Hologic Stock? - Barchart.com
Is Hologic (HOLX) Pricing Reflect Its Cash Flow Strength After Recent Stability In Diagnostics? - simplywall.st
Azzad Asset Management Inc. ADV Trims Position in Hologic, Inc. $HOLX - MarketBeat
Bone Mineral Densitometry (BMD) Market is expected to reach US$ - openPR.com
China approves Blackstone, TPG acquisition of medtech firm Hologic - The Economic Times
China market regulator: approved Blackstone and TPG's acquisition of medical technology company Hologic - marketscreener.com
Market Fear: Whats the profit margin of Hologic Inc2025 Technical Patterns & Smart Swing Trading Alerts - baoquankhu1.vn
Twin Capital Management Inc. Cuts Position in Hologic, Inc. $HOLX - MarketBeat
Nuance Investments LLC Sells 1,017,410 Shares of Hologic, Inc. $HOLX - MarketBeat
US Market Recap: Does Hologic Inc have a sustainable dividendJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Hologic, Inc. $HOLX Holdings Cut by IQ EQ FUND MANAGEMENT IRELAND Ltd - MarketBeat
Hologic, Inc. (HOLX) Announces Shareholder Approval for Merger w - GuruFocus
Hologic Shareholders Approve Blackstone and TPG Buyout Deal - TipRanks
SA's Competition Commission approves proposed deal whereby Hopper parent intends to buy Hologic, without conditions - marketscreener.com
Hologic’s Aptima assay secures FDA approval for HPV primary screening - Medical Device Network
Machina Capital S.A.S. Buys 13,426 Shares of Hologic, Inc. $HOLX - MarketBeat
Hologic’s Aptima HPV assay receives FDA approval for primary screening By Investing.com - Investing.com Nigeria
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):